Updated Jul 16, 2026
Chapman Steven Leonard has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $61.24M.
Steven Leonard Chapman is the CEO and President of Natera, Inc., a company specializing in genetic testing and diagnostics. Under his leadership, Natera has focused on advancing non-invasive prenatal testing and genetic screening technologies.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 3.4K | $226.97 | $774K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 6.8K | $226.15 | $1.53M |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 1.6K | $224.99 | $367K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 1.4K | $223.91 | $323K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 6.5K | $223.34 | $1.45M |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 2.0K | $222.25 | $446K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 2.4K | $220.19 | $528K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 2.8K | $219.08 | $604K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 1.7K | $218.28 | $380K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 2.4K | $217.04 | $510K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 5.5K | $216.13 | $1.19M |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 1.3K | $214.83 | $279K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 2.5K | $213.44 | $534K |
| 2026-06-06 | NTRA | Natera, Inc. | S — Open-market sale | 832 | $212.42 | $177K |
| 2026-05-06 | NTRA | Natera, Inc. | S — Open-market sale | 902 | $206.16 | $186K |
| 2026-04-30 | NTRA | Natera, Inc. | S — Open-market sale | 3.6K | $204.39 | $729K |
| 2026-04-30 | NTRA | Natera, Inc. | S — Open-market sale | 2.3K | $203.75 | $463K |
| 2026-03-12 | NTRA | Natera, Inc. | S — Open-market sale [10b5-1] | 5.6K | $204.13 | $1.15M |
| 2026-03-12 | NTRA | Natera, Inc. | A — Grant or award [10b5-1] | 5.6K | — | |
| 2026-03-04 | NTRA | Natera, Inc. | S — Open-market sale [10b5-1] | 365 | $201.18 | $73K |
Steven Leonard Chapman is the CEO and President of Natera, Inc., a company specializing in genetic testing and diagnostics. Under his leadership, Natera has focused on advancing non-invasive prenatal testing and genetic screening technologies.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 58 open-market sales ($61.24M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chapman Steven Leonard profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.